A regional growth nonprofit company has opened in Rockville a facility that can stockpile monoclonal antibodies and examine 100 pathogens, together with COVID-19, SARS-2, Ebola and MERS.
Connected DMV has opened its Global Pandemic Prevention and Biodefense Center on the U.S. Pharmacopeia constructing on Twinbrook Parkway, close to the National Institutes for Health.
“When an outbreak occurs, the idea is to stop it by having solutions prepared in advance,” mentioned Connected DMV CEO Stu Solomon. “To have antibodies prepared will allow us to provide preventative care, treatment and a cure to the infected.”
The center’s AHEAD100 initiative brings collectively dozens of consultants from the scientific, educational and nonprofit communities to speed up growth, Mr. Solomon mentioned.
“The federal government, academia and pharmaceuticals industry can’t solve this on their own,” he mentioned. “But when you bring them together, it’s amazing what can be done from a nonpartisan, public health perspective.”
The center raised $2.5 million final 12 months from its major companions: the Bill and Melinda Gates Foundation, the Maryland Department of Commerce, Montgomery County and Boston University’s Center for Emerging Infectious Diseases Policy and Research.
It hopes to increase $2.5 billion this 12 months — about $25 million per pathogen for growth — from non-public charities, the federal authorities and international governments.
Connected DMV mentioned it selected to set up the center in Montgomery County due to its proximity to 70 federal labs, 800 life sciences firms, 4 authorities well being businesses, political energy and 175 international embassies and missions in the D.C. space.
The new Rockville workplace will enable Connected DMV employees to submit analysis proposals to obtain the federal government and philanthropic grants they want to increase into analysis and lab house.
Dr. James Crowe, a pediatrician and infectious illness specialist who studied on the NIH, will function the center’s chief scientist.
“The last three years have clearly shown that our pandemic offense must include a full arsenal of medical countermeasures, stockpiled and ready to deploy anywhere in the world when an outbreak occurs,” mentioned Dr. Crow, a steering committee interim board member.
“Future outbreaks are inevitable, but another pandemic doesn’t have to be — what we do next will determine if we truly have the courage to prepare,” he mentioned.
Other board members embody Dr. Richard Tubb, former White House doctor to President George W. Bush, and Dr. Sachiko Kuno from the cosponsoring Sachiko Kuno Foundation.
Dr. Nahid Bhadelia, an infectious illnesses specialist, represents the Boston University School of Medicine on the steering committee. The college’s Center for Emerging Infectious Diseases Policy and Research, which she based, mentioned in an announcement that it “will provide expertise and strategic guidance for the new venture.”